CELT ACD VASCULAR CLOSURE DEVICE
Vasorum, Ltd. · Decision date Jul 20, 2016
What did the FDA approve?
The FDA approved the Celt ACD Vascular Closure Device on July 20, 2016, under PMA number P150006. The applicant was Vasorum, Ltd., and the device is categorized under product code MGB as a vascular hemostasis device in the cardiovascular specialty.
According to the FDA statement, the device is indicated for percutaneous closure of common femoral artery puncture sites while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional intra-arterial catheterization procedures where either 5F or 6F introducer sheaths have been used.
FDA approval order statement
Approval for the Celt ACD Vascular Closure Device. This device is indicated for the percutaneous closure of common femoral artery puncture sites while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional intra-arterial catheterization procedures where either 5F or 6F introducer sheaths have been used.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 20, 2016
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150006
- Regulatory pathway
- Premarket approval application
- Applicant
- Vasorum, Ltd.
- Product code
- MGB
- Decision code
- APPR
- Decision date
- Jul 20, 2016
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, hemostasis, vascular.
- Applicant
- Vasorum, Ltd.
- Product code
- MGB
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P150006 received
Application receipt date recorded by FDA.
P150006 · FDA decision
APPR
P150006/S009 · Related supplement
CELT ACD VASCULAR CLOSURE DEVICE
Timeline entries are records held by MedtechLedger for P150006. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150006
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CELT ACD VASCULAR CLOSURE DEVICEP150006/S009 | Vasorum, Ltd. | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MGB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott Vascular, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Oct 26, 2026 | FDA | |
| Vivasure Medical , Ltd. | PMA approval | Oct 16, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
VASCADE 5F Vascular Closure SystemP120016/S043 | Cardiva Medical, Inc. | PMA supplement | Sep 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Vasorum, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2012 Orchard Ave., Citywest Business Campus, Dublin, 24
Sources and methodology
- Original FDA record: P150006
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


